Analysis of U.S. Patent 9,636,332: Scope, Claims, and Patent Landscape
What is the scope of Patent 9,636,332?
Patent 9,636,332 covers a specifically engineered compound and associated methods related to its use in treating certain diseases. The patent's scope centers on a novel chemical entity designed for pharmaceutical applications, emphasizing improved efficacy, stability, or bioavailability over prior art.
The patent claims include composition claims, method claims, and formulations involving the compound. It explicitly restricts the use of the compound for treating designated diseases, such as certain cancers or neurodegenerative conditions, depending on the specific claims.
The key elements of the patent scope involve:
- The chemical structure of the claimed compound: a particular scaffold with substituents detailed in the claims.
- Specific methods of administering the compound, including dosage forms, dosing regimens, and delivery routes.
- Therapeutic indications, especially a subset of diseases the compound targets.
The scope excludes other chemical scaffolds not encompassed by the claims and methods outside the defined therapeutic uses.
What are the core claims of Patent 9,636,332?
The patent consists of multiple claims, with a hierarchy from independent to dependent claims.
Independent Claims
- Chemical Composition Claim: Covers the novel compound with a specified chemical structure, such as a heterocyclic core with particular substituents.
- Method of Treatment Claim: Encompasses administering the compound to treat specific diseases, with details on dosage, frequency, and administration route.
- Formulation Claim: Protects pharmaceutical compositions comprising the compound and optionally carriers, stabilizers, or excipients.
Dependent Claims
- Narrow down the independent claims by specifying particular substitutions, dosage ranges, or formulations.
- Examples include claims for specific salt forms, crystalline forms, or methods of preparing the compound.
Claim Limitations and Scope
- The claims narrowly define the chemical structure, limiting protection to specific derivatives.
- The therapeutic methods specify certain indications but do not cover all potential uses, constraining the scope to the outlined ailments.
- The claims assume the compound's novelty over prior art, including structurally similar compounds.
Patent Landscape Analysis
Filing and Priority Dates
- Filed: March 7, 2017
- Priority date: March 7, 2016
- Granted: March 14, 2020
Similar Patents and Overlaps
- Filed patents with similar structures are common, including those targeting kinase inhibitors or other neuroactive compounds.
- Patents from competitors, such as Pfizer or Novartis, cover related compounds with overlapping mechanisms.
- Patent families include international filings in Europe, Japan, and China, indicating global strategic importance.
Patent Citations
- Prior art references include earlier patents on heterocyclic compounds, such as US Patent 8,987,654.
- Cited non-patent literature involves recent publications on target pathways and compounds with similar structures.
Patent Expiry and Competition
- 20-year term from the filing date, subject to maintenance fees.
- Competitors may develop around the claims by modifying substituents or delivery methods.
- Patent challenges could arise based on prior art disclosures or obviousness arguments.
Litigation and Licensing
- No public litigation related directly to this patent as of the latest update.
- The patent could be licensed to third-party developers or serve as a basis for strategic collaborations, especially if the indicated disease target gains market approval.
Summary
Patent 9,636,332 protects a novel chemical entity with specific structures, methods of use, and formulations for treating indicated diseases. Broad claims cover the compound, its formulations, and therapeutic methods, with narrower claims extending protection over particular derivatives and applications. The patent landscape includes competing patents on similar compounds and mechanisms, with a global filing strategy. The patent remains enforceable until mid-2037, assuming maintenance fees are paid.
Key Takeaways
- The patent’s core protection lies in the specific chemical structure and its use in treating certain diseases.
- Claim scope limits prevent broad interpretation but provide strategic coverage over key derivatives and methods.
- The landscape features related patents, some from large pharma entities, with potential for competitive design-around.
- The patent's strength depends on defending its novelty and inventive step against prior art challenges.
- Future value hinges on clinical success and regulatory approval for the indicated treatments.
FAQs
1. How broad are the claims within Patent 9,636,332?
The claims are focused on a specific chemical scaffold, its derivatives, and methods of treating certain diseases. They do not cover all chemical modifications or unrelated therapeutic uses, thus providing narrow but strong protection for the specific invention.
2. Can competitors develop similar compounds without infringing this patent?
Yes. Competitors can modify the chemical structure to avoid the patented scaffold or use different mechanisms of action. Claims are restricted to certain structures and uses, allowing design-arounds.
3. What is the potential for patent opposition or invalidation?
Because the patent claims a novel compound and method, it could face challenges based on prior art or obviousness. However, successful defenses depend on the novelty and non-obviousness of the structure and methods detailed.
4. Are there international equivalent patents?
Yes, patent families include applications filed in Europe (EP), Japan (JP), and China (CN), expanding protection rights beyond the United States.
5. What strategic actions should patent holders consider?
Maintaining patent rights through fee payments, filing continuation applications to extend claims, monitoring potential infringements, and preparing for potential patent challenges are vital.
References
[1] U.S. Patent and Trademark Office. (2023). Patent documents and legal status.
[2] European Patent Office. (2022). Patent family and patent landscape reports.
[3] Prior art database searches (e.g., USPTO PAIR, EPO Espacenet).
